45

Tianda Pharmaceuticals LtdHKG 455 Stock Report

Last reporting period 30 Jun, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.031

Micro

Exchange

XHKG - Hong Kong Exchange

455.HK Stock Analysis

45

Uncovered

Tianda Pharmaceuticals Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.031

Dividend yield

2.18 %

Shares outstanding

2 150.04 B

Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. The company employs 699 full-time employees The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The firm operates businesses in Hong Kong, China and Australia.

View Section: Eyestock Rating